Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)        
Revenue, net $ 769,000 $ 937,000 $ 1,663,000 $ 2,449,000
Cost of revenue 2,438,000 807,000 4,786,000 2,069,000
Gross profit (deficit) (1,669,000) 130,000 (3,123,000) 380,000
Operating Expenses:        
Research and development 1,838,000 1,939,000 5,664,000 5,359,000
Sales and marketing 1,404,000 1,539,000 3,787,000 4,165,000
General and administrative 1,428,000 1,400,000 4,260,000 3,608,000
Total operating expenses 4,670,000 4,878,000 13,711,000 13,132,000
Loss from operations (6,339,000) (4,748,000) (16,834,000) (12,752,000)
Interest expense, net (52,000) (173,000) (812,000) (174,000)
Change in fair value of warrant liabilities 284,000 274,000 6,134,000 274,000
Loss on debt extinguishment     (837,000)  
Other expense, net (4,000) (2,000) (7,000) (7,000)
Loss before provision for income taxes (6,111,000) (4,649,000) (12,356,000) (12,659,000)
Provision for income taxes 0 0 2,000 2,000
Net loss $ (6,111,000) $ (4,649,000) $ (12,358,000) $ (12,661,000)
Net loss - basic $ (0.97) $ (30.85) $ (2.96) $ (84.55)
Net loss - diluted $ (0.97) $ (30.85) $ (2.96) $ (84.55)
Weighted average number of common shares used in computing net loss - Basic 6,322,464 150,705 4,179,089 149,751
Weighted average number of common shares used in computing net loss - Diluted 6,322,464 150,705 4,179,089 149,751